RT Journal Article
T1 Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.
A1 Kowalski, Marek L
A1 Ansotegui, Ignacio
A1 Aberer, Werner
A1 Al-Ahmad, Mona
A1 Akdis, Mubeccel
A1 Ballmer-Weber, Barbara K
A1 Beyer, Kirsten
A1 Blanca, Miguel
A1 Brown, Simon
A1 Bunnag, Chaweewan
A1 Capriles Hulett, Arnaldo
A1 Castells, Mariana
A1 Chng, Hiok Hee
A1 De Blay, Frederic
A1 Ebisawa, Motohiro
A1 Fineman, Stanley
A1 Golden, David B K
A1 Haahtela, Tari
A1 Kaliner, Michael
A1 Katelaris, Connie
A1 Lee, Bee Wah
A1 Makowska, Joanna
A1 Muller, Ulrich
A1 Mullol, Joaquim
A1 Oppenheimer, John
A1 Park, Hae-Sim
A1 Parkerson, James
A1 Passalacqua, Giovanni
A1 Pawankar, Ruby
A1 Renz, Harald
A1 Rueff, Franziska
A1 Sanchez-Borges, Mario
A1 Sastre, Joaquin
A1 Scadding, Glenis
A1 Sicherer, Scott
A1 Tantilipikorn, Pongsakorn
A1 Tracy, James
A1 van Kampen, Vera
A1 Bohle, Barbara
A1 Canonica, G Walter
A1 Caraballo, Luis
A1 Gomez, Maximiliano
A1 Ito, Komei
A1 Jensen-Jarolim, Erika
A1 Larche, Mark
A1 Melioli, Giovanni
A1 Poulsen, Lars K
A1 Valenta, Rudolf
A1 Zuberbier, Torsten
K1 Alérgenos
K1 Consenso
K1 Desensibilización inmunológica
K1 Humanos
K1 Hipersensibilidad
K1 Pruebas cutáneas
K1 Especialización
K1 Vacunas
AB One of the major concerns in the practice of allergy is related to the safety of procedures for the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of hypersensitivity disorders involves often intentional exposure to potentially allergenic substances (during skin testing), deliberate induction in the office of allergic symptoms to offending compounds (provocation tests) or intentional application of potentially dangerous substances (allergy vaccine) to sensitized patients. These situations may be associated with a significant risk of unwanted, excessive or even dangerous reactions, which in many instances cannot be completely avoided. However, adverse reactions can be minimized or even avoided if a physician is fully aware of potential risk and is prepared to appropriately handle the situation. Information on the risk of diagnostic and therapeutic procedures in allergic diseases has been accumulated in the medical literature for decades; however, except for allergen specific immunotherapy, it has never been presented in a systematic fashion. Up to now no single document addressed the risk of the most commonly used medical procedures in the allergy office nor attempted to present general requirements necessary to assure the safety of these procedures. Following review of available literature a group of allergy experts within the World Allergy Organization (WAO), representing various continents and areas of allergy expertise, presents this report on risk associated with diagnostic and therapeutic procedures in allergology and proposes a consensus on safety requirements for performing procedures in allergy offices. Optimal safety measures including appropriate location, type and required time of supervision, availability of safety equipment, access to specialized emergency services, etc. for various procedures have been recommended. This document should be useful for allergists with already established practices and experience as well as to other specialists taking care of patients with allergies.
PB Biomed Central
YR 2016
FD 2016-10-12
LK http://hdl.handle.net/10668/2660
UL http://hdl.handle.net/10668/2660
LA en
NO Kowalski ML, Ansotegui I, Aberer W, Al-Ahmad M, Akdis M, Ballmer-Weber BK, et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J. 2016; 9(1):33
NO JOURNAL ARTICLE;
DS RISalud
RD Apr 7, 2025